Arcutis Biotherapeutics, Inc. ARQT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$11.3M— | —— | $7.41M+147% | -$15.89M+36.6% | -$25.06M-132% | ||
| $10.69M+6.3% | $10.06M+0.2% | $10.04M-4.3% | $10.49M+7.3% | $9.78M+4.1% | ||
| $2.24M— | —— | -$1.75M— | —— | -$30.38M-3,961% | ||
| $0— | —— | —— | $78K-87.2% | $608K— | ||
| -$11.33M+66.8% | -$34.18M-35.4% | -$25.25M-245% | $17.42M+48.3% | $11.75M-66.3% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $1.07M-71.3% | $3.72M+152% | $1.48M+7.0% | $1.38M+249% | $395K— | ||
| -$8.15M-93.3% | -$4.21M+83.6% | -$25.62M-233% | $19.33M+206% | -$18.23M+71.3% | ||
| $2.24M— | —— | -$1.75M— | —— | -$30.99M-4,043% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Arcutis Biotherapeutics, Inc. generate?
- Arcutis Biotherapeutics, Inc. (ARQT) generated -$30.6M in operating cash flow over the trailing twelve months.
- What is Arcutis Biotherapeutics, Inc.'s free cash flow?
- After $686.0K of capital expenditures, Arcutis Biotherapeutics, Inc.'s free cash flow was -$31.3M over the trailing twelve months, up 81.4% year over year.
- Where does Arcutis Biotherapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Arcutis Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
